HealthcareAs of 2026-03-31
Joseph Edelman
Perceptive Advisors LLC
Founder of Perceptive Advisors. Healthcare and biotech specialist investor with exceptional expertise in analyzing pharmaceutical pipelines and FDA approvals.
$5.10BAUM
82Holdings
2026-03-31 Summary
6개 종목 신규 매수 (IONS, DMRA, RVMD 등) · 6개 종목 추가 매수 (SABS, RLAY, CRVS 등) · 32개 비중 축소 · 1 PUT (MRNA) · Top holding: PRAX 12.9%
Portfolio Heatmap
Size = portfolio weight · Green = added · Red = reducedThis Quarter's Trades
2026-03-31 기준New Buy6
IONSIONIS PHARMACEUTICALS INC$37.85M0.7%
DMRADAMORA THERAPEUTICS INC$31.68M0.6%
RVMDREVOLUTION MEDICINES INC$25.15M0.5%
DBVTDBV TECHNOLOGIES S A$20.15M0.4%
STROSUTRO BIOPHARMA INC$17.82M0.3%
EVMNEVOMMUNE INC$10.31M0.2%
Holdings
82 positions| # | Stock ⇅ | Weight ⇅ | Shares | Value | Change ⇅ | Trend |
|---|---|---|---|---|---|---|
| 1 |  PRAXPRAXIS PRECISION MEDICINES I | 12.87% | 2,035,986 | $655.97M | +2.00% | Added |
| 2 |  CELCCELCUITY INC | 7.01% | 3,127,200 | $356.94M | -1.04% | Partial Sell |
| 3 |  ROIVROIVANT SCIENCES LTD | 4.50% | 8,285,461 | $229.51M | +3.76% | Added |
| 4 |  CNTACENTESSA PHARMACEUTICALS PLC | 4.10% | 5,258,903 | $208.88M | +80.25% | Added |
| 5 |  RYTMRHYTHM PHARMACEUTICALS INC | 4.05% | 2,373,795 | $206.45M | -6.78% | Partial Sell |
| 6 |  SYRESPYRE THERAPEUTICS INC | 3.75% | 3,783,225 | $190.83M | +23.26% | Added |
| 7 |  NUVLNUVALENT INC | 3.18% | 1,580,505 | $161.92M | -5.08% | Partial Sell |
| 8 |  EWTXEDGEWISE THERAPEUTICS INC | 2.74% | 4,423,974 | $139.36M | -0.76% | Partial Sell |
| 9 |  PTGXPROTAGONIST THERAPEUTICS INC | 2.55% | 1,230,879 | $129.73M | -8.85% | Partial Sell |
| 10 |  APGEAPOGEE THERAPEUTICS INC | 2.54% | 1,540,384 | $129.65M | -33.91% | Partial Sell |
Options Positions
2개 포지션CALL
10.1% 비중
PUT
11.0% 비중
P/C Ratio
1.00
| Ticker | Type | Weight | Value | Chg | Activity |
|---|---|---|---|---|---|
MRNA MODERNA INC | PUT | 1.00% | $50.80M | 0.0% | New |
OCUL OCULAR THERAPEUTIX INC | CALL | 0.08% | $4.24M | 0.0% | New |
* 풋(PUT) 옵션은 주가 하락에 베팅하는 포지션, 콜(CALL) 옵션은 주가 상승에 베팅하는 포지션입니다.
* 풋/콜 비율이 1보다 크면 방어적, 작으면 공격적 성향으로 해석됩니다.
FAQ
Need Deeper Analysis?
Track Joseph Edelman's portfolio changes in real-time,
compare gurus head-to-head, and analyze performance vs S&P 500 with Premium.